Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
4884047
Reference Type
Journal Article
Title
Anti-insulin resistance effects of diarylheptanoids and flavonoids from Myrica rubra leaves
Author(s)
Chen, P; Yang, CHsu; Yao, JY; Xia, J; Zheng, W; Wu, X; Li, J; Wang, Y; Wang, GH; Xu, J; Luo, L; Chen, YH
Year
2018
Is Peer Reviewed?
1
Journal
Minerva Biotecnologica
ISSN:
1120-4826
Volume
30
Issue
1
Page Numbers
1-6
DOI
10.23736/S1120-4826.17.02246-7
Web of Science Id
WOS:000429096200001
Abstract
BACKGROUND: Some human metabolic enzymes, including AMPK, Acetyl-CoA carboxylase, E1 ubiquitin activating enzyme, glycogen synthase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), are key indexes of metabolic disorders caused by type II diabetes. These enzymes are important for insulin regulation and stability maintenance of the human body.
METHODS: We analyzed the effects of (2R)-3',4"-epoxy-2-hydroxy-1-(4-hydroxyphenyl)-7-(3-methoxyphenyl) heptan-3-one (compound 1), myricanol (compound 2), myricetin (compound 3) and myricitrin (compound 4) extracted from Myrica rubra leaves on type II diabetes.
RESULTS: We discovered that 2R)-3',4"-epoxy-2-hydroxy-1-(4-hydroxyphenyl)-7-(3-methoxyphenyl) heptan-3-one (compound 1) was the best compound to relieve metabolic disorders caused by type II diabetes.
CONCLUSIONS: We concluded that the four compounds promoted glycogen synthesis and improved the overall effectiveness of carbohydrate metabolism.
Keywords
Myrica; Motor activity; Diabetes mellitus, type 2; Metabolic diseases
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity